College of Social and Behavioral Sciences
School of Psychology
Karen Gil received her Ph.D. in physiological psychology at the University of Massachusetts, studying peripheral metabolism. She studied metabolism during trauma as a post-doctoral fellow at Columbia in New York City. She received a certificate in Public Health from Johns Hopkins University, supporting her transition to a clinical outcomes researcher. Her recent work is in quality of life in women with gynecologic malignancies, in part as a 14 year member of an NCI funded Cancer Cooperative Group that designs clinical trials for people with cancer. She is an author of 48 peer reviewed publications, and over 70 chapters, reviews and national presentations.
BS, Tufts University
PhD, Univ MA, Amherst, MA
Post-master's Certificate, Johns Hopkins Bloomberg School of Public Health
Awards / Honors
Faculty Excellence Award, Department of Medical Education, Summa Health, Akron OH, 2019
Foundations of Clinical Medicine Course Excellence in Teaching Award, Department of Family and Community Medicine, NEOMED, 2018
Gil, K. M., Stephanie, P., Klopp, A., Yeung, A. (2019). Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy Gynecologic Oncology
Scott, E., Gil, K. M., King, B., Piatt, E. (2015). Clinical outcomes in a primary care practice within a Center for Health Equity J Prim Care Community Health
Klopp, A., Yeung, A., Deshmukh, S., Gil, K. M. (2018). Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203 Journal of Clinical Oncology
Pfefferle, K., Gil, K. M., Fening, S., Dilisio, M. (2014). Validation study of a pooled electronic healthcare database: the effect of obesity on the revision rate of total knee arthroplasty. Eur J Orthop Surg Traumatol.
Yeung, A., Pugh, S., Klopp, A., Gil, K. M. (2016). Clinicians underreport adverse events in NRG Oncology’s RTOG 1203: The importance of using patient-reported outcomes in oncology clinical trials. American Society for Radiation Oncology (ASTRO)